Colorectal cancer treatment assisted by robotic platforms - a systematic review
Robotic colorectal surgery (RCS) demonstrated superior intraoperative control, lower conversion rates, and enhanced lymphadenectomy precision, though with longer operative times and higher procedural costs compared to laparoscopic surgery (LS).
This study aims to analyze and describe robotic assisted surgery approach in colorectal cancer therapy and evaluate its effectiveness in comparison to the laparoscopic approach. Apart from assessing surgical metrics, such as intraoperative precision and complication rates, the study also explores broader aspects, including the impact on patients9s quality of life, the frequency of conversions to open surgery, and the oncological quality of resections. By incorporating these complementary factors, the analysis provides a comprehensive perspective on the role of robotic surgery in colorectal cancer treatment.
It highlights the perioperative and functional benefits of robotic surgery for colorectal cancer patients, especially in anatomically challenging cases, informing clinical decision‑making and future research.
Evidence level: Állatkísérletes. Állatmodellben vizsgálták.
Related signals
- Encorafenib, Binimetinib, and Cetuximab in BRAF V600E‑Mutated Colorectal Cancer
- Current and emerging therapeutic approaches for colorectal cancer: A comprehensive review
- Three Versus 6 Months of Adjuvant Oxaliplatin‑Fluoropyrimidine Chemotherapy for Colorectal Cancer: Final Results of SCOT—An International, Randomized, Phase III, Noninferiority Trial
- Duration of Adjuvant Chemotherapy for Stage III Colon Cancer
- Emerging and Established Targets in Colorectal Cancer: Translating Biology Into Therapeutics